Dysregulated phosphorylation and nuclear translocation of cyclic AMP response element binding protein (CREB) in rat liver after chronic ethanol binge-Reference-Cited by-同舟云学术

Dysregulated phosphorylation and nuclear translocation of cyclic AMP response element binding protein (CREB) in rat liver after chronic ethanol binge

Published:2012-03 Issue:1-3 Volume:679 Page:101-108
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Aroor Annayya R.,Jackson Daniel E.,Shukla Shivendra D.

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmacology

Reference51 articles.

1. MAP kinase signaling in diverse effects of ethanol;Aroor;Life Sci.,2004

2. Binge ethanol intake in chronically exposed rat liver decreased LDL-receptor and increased angiotensinogen gene expression;Aroor;World J. Hepatol.,2011

3. Activation of MEK 1/2 and p42/44 MAPK by angiotensin II in hepatocyte nucleus and their potentiation by ethanol;Aroor;Alcohol,2009

4. Impaired nuclear accumulation of phosphorylation of CREB in rat liver in vivo after ethanol binge in chronic ethanol treated rats;Aroor;Alcohol. Clin. Exp. Res.,2010

5. Elevated activation of ERK-1 and ERK-2 accompany enhanced liver injury following alcohol binge in chronically ethanol fed rats;Aroor;Alcohol. Clin. Exp. Res.,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment;Medicinal Chemistry Research;2024-06-26

2. New insights into the downregulation of cytochrome P450 2E1 via nuclear factor κB-dependent pathways in immune-mediated liver injury;Heliyon;2023-12

3. Levistolide A ameliorates fibrosis in chronic kidney disease via modulating multitarget actions in vitro and in vivo;Life Sciences;2023-05

4. Laminarin ameliorates alcohol‐induced liver damage and its molecular mechanism in mice;Journal of Food Biochemistry;2022-12

5. Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease;Pharmaceutics;2022-09-07